Preferential activation by galanin 1–15 fragment of the GalR1 protomer of a GalR1–GalR2 heteroreceptor complex-Reference-Cited by-同舟云学术

Preferential activation by galanin 1–15 fragment of the GalR1 protomer of a GalR1–GalR2 heteroreceptor complex

Published:2014-09 Issue:3 Volume:452 Page:347-353
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Borroto-Escuela Dasiel O.,Narvaez Manuel,Di Palma Michael,Calvo Feliciano,Rodriguez David,Millon Carmelo,Carlsson Jens,Agnati Luigi F.,Garriga Pere,Díaz-Cabiale Zaida,Fuxe Kjell

Funder

Swedish Medical Research Council

Telethon TV3’s La Marató Foundation

AFA Försäkring

Proyecto Excelencia

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference15 articles.

1. Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex;Fuxe;Neurosci. Lett.,1988

2. Galanin/5-HT interactions in the rat central nervous system. Relevance for depression;Fuxe,1991

3. Receptor–receptor interactions within receptor mosaics, Impact on neuropsychopharmacology;Fuxe;Brain. Res. Rev.,2008

4. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization;Borroto-Escuela;Biochem. Biophys. Res. Commun.,2010

5. Molecular biology and pharmacology of galanin receptors;Branchek;Ann. N. Y. Acad. Sci.,1998

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Class A and C GPCR Dimers in Neurodegenerative Diseases;Current Neuropharmacology;2022-11

2. Galanin N-terminal fragment (1−15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system;Biomedicine & Pharmacotherapy;2022-09

3. The Galaninergic System: A Target for Cancer Treatment;Cancers;2022-08-01

4. Anxiety and Depression: What Do We Know of Neuropeptides?;Behavioral Sciences;2022-07-29

5. Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders;Cells;2022-06-02